Suppr超能文献

使用内镜黏膜下剥离术或全层切除术器械治疗内镜切除后结直肠残留肿瘤:一项多中心历史队列研究。

Use of endoscopic submucosal dissection or full-thickness resection device to treat residual colorectal neoplasia after endoscopic resection: a multicenter historical cohort study.

机构信息

Endoscopy and Gastroenterology Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.

Endoscopy and Gastroenterology Unit, Hospital Saint Joseph, Paris, France.

出版信息

Endoscopy. 2023 Nov;55(11):1002-1009. doi: 10.1055/a-2116-9930. Epub 2023 Jul 27.

Abstract

INTRODUCTION

Residual colorectal neoplasia (RCN) after previous endoscopic mucosal resection is a frequent challenge. Different management techniques are feasible including endoscopic full-thickness resection using the full-thickness resection device (FTRD) system and endoscopic submucosal dissection (ESD). We aimed to compare the efficacy and safety of these two techniques for the treatment of such lesions. METHODS : All consecutive patients with RCN treated either using the FTRD or by ESD were retrospectively included in this multicenter study. The primary outcome was the R0 resection rate, defined as an en bloc resection with histologically tumor-free lateral and deep margins. RESULTS : 275 patients (median age 70 years; 160 men) who underwent 177 ESD and 98 FTRD procedures for RCN were included. R0 resection was achieved in 83.3 % and 77.6 % for ESD and FTRD, respectively ( = 0.25). Lesions treated by ESD were however larger than those treated by FTRD ( < 0.001). The R0 rates for lesions of 20-30 mm were 83.9 % and 57.1 % in the ESD and FTRD groups, respectively, and for lesions of 30-40 mm were 93.6 % and 33.3 %, respectively. On multivariable analysis, ESD procedures were associated with statistically higher en bloc and R0 resection rates after adjustment for lesion size ( = 0.02 and  < 0.001, respectively). The adverse event rate was higher in the ESD group (16.3 % vs. 5.1 %), mostly owing to intraoperative perforations. CONCLUSION:  ESD is effective in achieving R0 resection for RCN whatever the size and location of the lesions. When residual lesions are smaller than 20 mm, the FTRD is an effective alternative.

摘要

介绍

经内镜黏膜切除术(EMR)后残留的结直肠腺瘤(RCN)是一个常见的挑战。可行的治疗方法包括使用全层切除术(FTRD)系统进行内镜全层切除术和内镜黏膜下剥离术(ESD)。我们旨在比较这两种技术治疗此类病变的疗效和安全性。

方法

回顾性纳入本多中心研究中接受 FTRD 或 ESD 治疗的所有 RCN 连续患者。主要结局是 R0 切除率,定义为具有无肿瘤性侧向和深层切缘的整块切除。

结果

共纳入 275 例(中位年龄 70 岁;男性 160 例)患者,接受了 177 例 ESD 和 98 例 FTRD 治疗 RCN。ESD 和 FTRD 的 R0 切除率分别为 83.3%和 77.6%( = 0.25)。然而,ESD 治疗的病变大于 FTRD 治疗的病变( < 0.001)。ESD 和 FTRD 治疗 20-30mm 病变的 R0 率分别为 83.9%和 57.1%,治疗 30-40mm 病变的 R0 率分别为 93.6%和 33.3%。多变量分析显示,在调整病变大小后,ESD 手术与更高的整块和 R0 切除率相关( = 0.02 和  < 0.001)。ESD 组的不良事件发生率较高(16.3%比 5.1%),主要是由于术中穿孔。

结论

无论病变的大小和位置如何,ESD 对于 RCN 均能有效实现 R0 切除。当残留病变小于 20mm 时,FTRD 是一种有效的替代方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验